Endoscopic-assisted orbital exenteration: Technical feasibility and surgical results from a single-center consecutive series. Issue 2 (February 2022)

• Record Type: Journal Article
• Authors: Turri-Zanoni, Mario; Arosio, Alberto Daniele; Agosti, Edoardo; Battaglia, Paolo; Cherubino, Mario; Balbi, Sergio; Margherini, Stefano; Locatelli, Davide; Valdatta, Luigi; Castelnuovo, Paolo
• Is Part Of: Journal of cranio-maxillofacial surgery. Volume 50:Issue 2(2022)
• Page Start: 156
• Page End: 162
• Publication Date: 2022-02
• Subjects: Endoscopic endonasal approach -- Orbital exenteration -- Orbital apex -- Sinonasal malignancy -- Skull base; Skull -- Surgery -- Periodicals; Maxilla -- Surgery -- Periodicals; Face -- Surgery -- Periodicals; Surgery, Plastic -- Periodicals; Maxilla -- surgery -- Periodicals; Face -- surgery -- Periodicals; Skull -- surgery -- Periodicals; Oral Surgical Procedures -- Periodicals; Reconstructive Surgical Procedures -- Periodicals; Surgery, Plastic -- Periodicals; Surgery, Oral -- Periodicals; Electronic journals; 617.514
• DOI: 10.1016/j.jcms.2021.11.005
• Languages: English
• ISSNs: 1010-5182

Abstract

Abstract: The purposes of this study were to describe the endoscopic-assisted orbital exenteration surgical techniques, to report preliminary outcomes and to discuss advantages, indications and limitations of this approach. All patients who underwent endoscopic-assisted orbital exenteration at a single tertiary-care center were retrospectively reviewed. A concomitant reconstruction was performed in all cases. The extent of surgical resection was tailored to the size and location of tumor and was classified into four subtypes. A total of 40 patients were included in this series. Orbital exenteration type 1 was performed in 7 cases, type 2 in 11 cases, type 3 in 19 cases, and type 4 in 3 cases. The reconstruction was performed with a pedicled temporal flap in 5 patients and with a free vascularized flap in 34 cases. A radical resection of disease was obtained in 32 cases. After a mean follow-up of 36 months, 14 patients died of disease, one patient died of other causes, 7 are alive with disease, and 18 patients are currently alive without evidence of disease. The preliminary data emerging from this case-series support the feasibility and safety of endoscopic-assisted orbital exenteration.